Utah Medical Products, Inc. (UTMD)
USD 62.0
(-0.85%)
USD 62.0
(-0.85%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 13.26 Million USD | -52.37% |
| 2022 | 12.4 Million USD | 3.07% |
| 2021 | 12.03 Million USD | 1.66% |
| 2020 | 11.84 Million USD | 0.05% |
| 2019 | 11.83 Million USD | 55.53% |
| 2018 | 7.6 Million USD | 3.05% |
| 2017 | 7.38 Million USD | -1.59% |
| 2016 | 7.5 Million USD | -12.08% |
| 2015 | 8.53 Million USD | -2.81% |
| 2014 | 8.78 Million USD | -7.03% |
| 2013 | 9.44 Million USD | -6.58% |
| 2012 | 10.11 Million USD | -4.24% |
| 2011 | 10.55 Million USD | 146.22% |
| 2010 | 4.28 Million USD | -1.58% |
| 2009 | 4.35 Million USD | -5.88% |
| 2008 | 4.62 Million USD | -8.01% |
| 2007 | 5.03 Million USD | -5.27% |
| 2006 | 5.31 Million USD | -18.48% |
| 2005 | 6.51 Million USD | 31.45% |
| 2004 | 4.95 Million USD | -4.12% |
| 2003 | 5.17 Million USD | -0.98% |
| 2002 | 5.22 Million USD | -14.62% |
| 2001 | 6.11 Million USD | -9.51% |
| 2000 | 6.75 Million USD | -30.37% |
| 1999 | 9.7 Million USD | 1.1% |
| 1998 | 9.6 Million USD | 11.63% |
| 1997 | 8.6 Million USD | -1.15% |
| 1996 | 8.7 Million USD | -8.42% |
| 1995 | 9.5 Million USD | 6.74% |
| 1994 | 8.9 Million USD | 3.49% |
| 1993 | 8.6 Million USD | 16.22% |
| 1992 | 7.4 Million USD | 51.02% |
| 1991 | 4.9 Million USD | 25.64% |
| 1990 | 3.9 Million USD | 11.43% |
| 1989 | 3.5 Million USD | 12.9% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 1.93 Million USD | 6.63% |
| 2024 Q2 | 2.3 Million USD | -20.01% |
| 2024 Q1 | 2.88 Million USD | 26.12% |
| 2023 Q2 | -3.31 Million USD | -197.36% |
| 2023 FY | 5.9 Million USD | -52.37% |
| 2023 Q3 | -3.39 Million USD | -2.29% |
| 2023 Q4 | 2.28 Million USD | 167.43% |
| 2023 Q1 | 3.4 Million USD | 4.51% |
| 2022 FY | 12.4 Million USD | 3.07% |
| 2022 Q1 | 3.01 Million USD | 0.94% |
| 2022 Q4 | 3.25 Million USD | 6.96% |
| 2022 Q2 | 3.09 Million USD | 2.76% |
| 2022 Q3 | 3.04 Million USD | -1.58% |
| 2021 Q1 | 3.05 Million USD | 2.48% |
| 2021 FY | 12.03 Million USD | 1.66% |
| 2021 Q4 | 2.98 Million USD | 0.27% |
| 2021 Q3 | 2.97 Million USD | -1.49% |
| 2021 Q2 | 3.02 Million USD | -1.27% |
| 2020 FY | 11.84 Million USD | 0.05% |
| 2020 Q1 | 2.97 Million USD | -5.2% |
| 2020 Q3 | 2.91 Million USD | -2.12% |
| 2020 Q4 | 2.98 Million USD | 2.58% |
| 2020 Q2 | 2.97 Million USD | 0.0% |
| 2019 Q4 | 3.13 Million USD | 4.26% |
| 2019 Q1 | 2.67 Million USD | 45.38% |
| 2019 FY | 11.83 Million USD | 55.53% |
| 2019 Q2 | 3.01 Million USD | 12.99% |
| 2019 Q3 | 3 Million USD | -0.36% |
| 2018 FY | 7.6 Million USD | 3.05% |
| 2018 Q1 | 1.95 Million USD | 2.85% |
| 2018 Q3 | 1.89 Million USD | -1.87% |
| 2018 Q4 | 1.83 Million USD | -2.85% |
| 2018 Q2 | 1.92 Million USD | -1.18% |
| 2017 Q4 | 1.89 Million USD | 4.4% |
| 2017 Q2 | 1.85 Million USD | 2.71% |
| 2017 FY | 7.38 Million USD | -1.59% |
| 2017 Q1 | 1.81 Million USD | -0.49% |
| 2017 Q3 | 1.81 Million USD | -2.26% |
| 2016 FY | 7.5 Million USD | -12.08% |
| 2016 Q1 | 1.91 Million USD | -8.52% |
| 2016 Q2 | 1.93 Million USD | 1.36% |
| 2016 Q3 | 1.83 Million USD | -5.21% |
| 2016 Q4 | 1.81 Million USD | -0.93% |
| 2015 Q3 | 2.07 Million USD | -2.49% |
| 2015 FY | 8.53 Million USD | -2.81% |
| 2015 Q2 | 2.13 Million USD | -4.61% |
| 2015 Q1 | 2.23 Million USD | 6.78% |
| 2015 Q4 | 2.08 Million USD | 0.48% |
| 2014 Q2 | 2.28 Million USD | 3.62% |
| 2014 Q4 | 2.09 Million USD | -4.6% |
| 2014 FY | 8.78 Million USD | -7.03% |
| 2014 Q3 | 2.19 Million USD | -4.07% |
| 2014 Q1 | 2.2 Million USD | -9.4% |
| 2013 Q1 | 2.39 Million USD | -2.41% |
| 2013 FY | 9.44 Million USD | -6.58% |
| 2013 Q2 | 2.33 Million USD | -2.47% |
| 2013 Q3 | 2.28 Million USD | -2.06% |
| 2013 Q4 | 2.43 Million USD | 6.61% |
| 2012 Q1 | 2.62 Million USD | -12.53% |
| 2012 FY | 10.11 Million USD | -4.24% |
| 2012 Q3 | 2.51 Million USD | -0.08% |
| 2012 Q2 | 2.51 Million USD | -4.0% |
| 2012 Q4 | 2.45 Million USD | -2.62% |
| 2011 Q1 | 1.55 Million USD | 40.58% |
| 2011 Q4 | 3 Million USD | 0.7% |
| 2011 Q2 | 3.02 Million USD | 95.04% |
| 2011 Q3 | 2.97 Million USD | -1.59% |
| 2011 FY | 10.55 Million USD | 146.22% |
| 2010 FY | 4.28 Million USD | -1.58% |
| 2010 Q4 | 1.1 Million USD | 2.32% |
| 2010 Q3 | 1.07 Million USD | 0.65% |
| 2010 Q2 | 1.07 Million USD | 3.68% |
| 2010 Q1 | 1.03 Million USD | -4.08% |
| 2009 Q4 | 1.07 Million USD | -3.41% |
| 2009 FY | 4.35 Million USD | -5.88% |
| 2009 Q3 | 1.11 Million USD | -0.53% |
| 2009 Q2 | 1.12 Million USD | 7.78% |
| 2009 Q1 | 1.04 Million USD | -13.18% |
| 2008 Q1 | 1.21 Million USD | -2.81% |
| 2008 Q3 | 997 Thousand USD | -18.48% |
| 2008 Q4 | 1.19 Million USD | 20.26% |
| 2008 FY | 4.62 Million USD | -8.01% |
| 2008 Q2 | 1.22 Million USD | 1.07% |
| 2007 FY | 5.03 Million USD | -5.27% |
| 2007 Q4 | 1.24 Million USD | -0.64% |
| 2007 Q3 | 1.25 Million USD | -2.72% |
| 2007 Q2 | 1.28 Million USD | 3.37% |
| 2007 Q1 | 1.24 Million USD | 2.13% |
| 2006 FY | 5.31 Million USD | -18.48% |
| 2006 Q1 | 1.37 Million USD | -23.91% |
| 2006 Q2 | 1.48 Million USD | 7.78% |
| 2006 Q4 | 1.22 Million USD | -1.21% |
| 2006 Q3 | 1.23 Million USD | -16.67% |
| 2005 FY | 6.51 Million USD | 31.45% |
| 2005 Q4 | 1.8 Million USD | -8.55% |
| 2005 Q3 | 1.97 Million USD | 27.4% |
| 2005 Q2 | 1.55 Million USD | 31.22% |
| 2005 Q1 | 1.18 Million USD | -2.56% |
| 2004 Q2 | 1.3 Million USD | 7.05% |
| 2004 Q3 | 1.21 Million USD | -6.74% |
| 2004 Q4 | 1.21 Million USD | -0.41% |
| 2004 FY | 4.95 Million USD | -4.12% |
| 2004 Q1 | 1.22 Million USD | -6.15% |
| 2003 Q2 | 1.32 Million USD | 4.43% |
| 2003 Q4 | 1.3 Million USD | 1.33% |
| 2003 FY | 5.17 Million USD | -0.98% |
| 2003 Q1 | 1.26 Million USD | -3.21% |
| 2003 Q3 | 1.28 Million USD | -2.88% |
| 2002 FY | 5.22 Million USD | -14.62% |
| 2002 Q1 | 1.29 Million USD | 251.46% |
| 2002 Q2 | 1.31 Million USD | 1.54% |
| 2002 Q3 | 1.3 Million USD | -0.84% |
| 2002 Q4 | 1.3 Million USD | 0.23% |
| 2001 Q2 | 1.57 Million USD | 2.08% |
| 2001 Q3 | 1.5 Million USD | -4.39% |
| 2001 Q4 | -855 Thousand USD | -156.96% |
| 2001 FY | 6.11 Million USD | -9.51% |
| 2001 Q1 | 1.53 Million USD | -0.39% |
| 2000 Q2 | 1.74 Million USD | -2.68% |
| 2000 Q3 | 1.67 Million USD | -3.9% |
| 2000 Q4 | 1.54 Million USD | -7.93% |
| 2000 Q1 | 1.79 Million USD | -25.48% |
| 2000 FY | 6.75 Million USD | -30.37% |
| 1999 Q2 | 2.3 Million USD | -4.17% |
| 1999 Q3 | 2.5 Million USD | 8.7% |
| 1999 Q4 | 2.4 Million USD | -3.76% |
| 1999 Q1 | 2.4 Million USD | -4.0% |
| 1999 FY | 9.7 Million USD | 1.1% |
| 1998 Q4 | 2.5 Million USD | 4.17% |
| 1998 FY | 9.6 Million USD | 11.63% |
| 1998 Q1 | 2.3 Million USD | 0.0% |
| 1998 Q2 | 2.4 Million USD | 4.35% |
| 1998 Q3 | 2.4 Million USD | 0.0% |
| 1997 Q2 | 1.9 Million USD | 0.0% |
| 1997 Q4 | 2.3 Million USD | -8.0% |
| 1997 Q3 | 2.5 Million USD | 31.58% |
| 1997 FY | 8.6 Million USD | -1.15% |
| 1997 Q1 | 1.9 Million USD | -9.52% |
| 1996 FY | 8.7 Million USD | -8.42% |
| 1996 Q4 | 2.1 Million USD | 5.0% |
| 1996 Q3 | 2 Million USD | -13.04% |
| 1996 Q2 | 2.3 Million USD | 9.52% |
| 1996 Q1 | 2.1 Million USD | -16.0% |
| 1995 Q1 | 2.2 Million USD | -8.33% |
| 1995 Q2 | 2.5 Million USD | 13.64% |
| 1995 FY | 9.5 Million USD | 6.74% |
| 1995 Q4 | 2.5 Million USD | 4.17% |
| 1995 Q3 | 2.4 Million USD | -4.0% |
| 1994 Q1 | 2.1 Million USD | -16.0% |
| 1994 FY | 8.9 Million USD | 3.49% |
| 1994 Q4 | 2.4 Million USD | 14.29% |
| 1994 Q3 | 2.1 Million USD | -8.7% |
| 1994 Q2 | 2.3 Million USD | 9.52% |
| 1993 Q3 | 2 Million USD | -9.09% |
| 1993 Q4 | 2.5 Million USD | 25.0% |
| 1993 Q1 | 1.9 Million USD | -17.39% |
| 1993 FY | 8.6 Million USD | 16.22% |
| 1993 Q2 | 2.2 Million USD | 15.79% |
| 1992 FY | 7.4 Million USD | 51.02% |
| 1992 Q3 | 1.7 Million USD | -5.56% |
| 1992 Q1 | 1.6 Million USD | 6.67% |
| 1992 Q4 | 2.3 Million USD | 35.29% |
| 1992 Q2 | 1.8 Million USD | 12.5% |
| 1991 Q2 | 1.3 Million USD | 18.18% |
| 1991 FY | 4.9 Million USD | 25.64% |
| 1991 Q4 | 1.5 Million USD | 50.0% |
| 1991 Q3 | 1 Million USD | -23.08% |
| 1991 Q1 | 1.1 Million USD | -8.33% |
| 1990 Q3 | 900 Thousand USD | 12.5% |
| 1990 Q2 | 800 Thousand USD | -11.11% |
| 1990 Q1 | 900 Thousand USD | -18.18% |
| 1990 Q4 | 1.2 Million USD | 33.33% |
| 1990 FY | 3.9 Million USD | 11.43% |
| 1989 Q4 | 1.1 Million USD | 22.22% |
| 1989 Q2 | 700 Thousand USD | 0.0% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q3 | 900 Thousand USD | 28.57% |
| 1989 FY | 3.5 Million USD | 12.9% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | 87.282% |
| AngioDynamics, Inc. | 252.41 Million USD | 94.746% |
| AtriCure, Inc. | 327.05 Million USD | 95.945% |
| Avinger, Inc. | 18.63 Million USD | 28.85% |
| Azenta, Inc. | 336.26 Million USD | 96.056% |
| BioLife Solutions, Inc. | 117.57 Million USD | 88.721% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 99.273% |
| Daxor Corporation | 1.28 Million USD | -935.599% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | 45.182% |
| Femasys Inc. | 15.2 Million USD | 12.758% |
| GlucoTrack, Inc. | 7.1 Million USD | -86.669% |
| Harvard Bioscience, Inc. | 58.58 Million USD | 77.363% |
| Hologic, Inc. | 1.34 Billion USD | 99.014% |
| ICU Medical, Inc. | 717.04 Million USD | 98.151% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 99.552% |
| KORU Medical Systems, Inc. | 26.1 Million USD | 49.207% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | 85.321% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 11212.973% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 11212.973% |
| Masimo Corporation | 867 Million USD | 98.47% |
| Microbot Medical Inc. | 9.85 Million USD | -34.561% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | 28.008% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 97.117% |
| Nephros, Inc. | 9.78 Million USD | -35.538% |
| NovoCure Limited | 613.92 Million USD | 97.84% |
| NEXGEL, Inc. | 4.09 Million USD | -223.755% |
| NEXGEL, Inc. | 4.09 Million USD | -223.755% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | 87.03% |
| OraSure Technologies, Inc. | 125.34 Million USD | 89.42% |
| Pro-Dex, Inc. | 7.37 Million USD | -79.737% |
| Pulse Biosciences, Inc. | 43.57 Million USD | 69.567% |
| Predictive Oncology Inc. | 15.22 Million USD | 12.926% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -55.607% |
| QuidelOrtho Corporation | 1.35 Billion USD | 99.022% |
| Repligen Corporation | 261.12 Million USD | 94.922% |
| Sanara MedTech Inc. | 61.12 Million USD | 78.306% |
| STAAR Surgical Company | 224.55 Million USD | 94.095% |
| Sharps Technology, Inc. | 10.12 Million USD | -30.951% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.261% |
| Jin Medical International Ltd. | 3.91 Million USD | -238.5% |